Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 6
2003 1
2004 12
2007 2
2008 1
2009 2
2010 2
2011 1
2012 1
2013 2
2014 1
2015 1
2016 3
2017 3
2018 4
2019 2
2020 3
2021 3
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD; KEYNOTE-671 Investigators. Wakelee H, et al. N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3. N Engl J Med. 2023. PMID: 37272513 Free PMC article. Clinical Trial.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group. Socinski MA, et al. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863955 Free article. Clinical Trial.
Lung Cancer in Lithuania.
Gedvilaitė V, Danila E, Cicėnas S, Smailytė G. Gedvilaitė V, et al. Among authors: cicenas s. J Thorac Oncol. 2020 Sep;15(9):1401-1405. doi: 10.1016/j.jtho.2020.02.029. J Thorac Oncol. 2020. PMID: 32854913 Free article. No abstract available.
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.
Cappuzzo F, Ciuleanu T, Stelmakh L, Cicenas S, Szczésna A, Juhász E, Esteban E, Molinier O, Brugger W, Melezínek I, Klingelschmitt G, Klughammer B, Giaccone G; SATURN investigators. Cappuzzo F, et al. Among authors: cicenas s. Lancet Oncol. 2010 Jun;11(6):521-9. doi: 10.1016/S1470-2045(10)70112-1. Epub 2010 May 20. Lancet Oncol. 2010. PMID: 20493771 Clinical Trial.
Extralobar pulmonary sequestration.
Ulys A, Samalavicius NE, Cicenas S, Petraitis T, Trakymas M, Sheinin D, Gatijatullin L. Ulys A, et al. Among authors: cicenas s. Int Med Case Rep J. 2011 Apr 1;4:21-3. doi: 10.2147/IMCRJ.S15261. Print 2011. Int Med Case Rep J. 2011. PMID: 23754900 Free PMC article.
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials.
Eide IJZ, Stensgaard S, Helland Å, Ekman S, Mellemgaard A, Hansen KH, Cicenas S, Koivunen J, Grønberg BH, Sørensen BS, Brustugun OT. Eide IJZ, et al. Among authors: cicenas s. Transl Lung Cancer Res. 2022 Jun;11(6):953-963. doi: 10.21037/tlcr-21-995. Transl Lung Cancer Res. 2022. PMID: 35832438 Free PMC article.
The Impact of the COVID-19 Pandemic on Cancer Patient's Management-Lithuanian Cancer Center Experience.
Dabkeviciene D, Vincerzevskiene I, Urbonas V, Venius J, Dulskas A, Brasiuniene B, Janulionis E, Burneckis A, Zileviciene A, Tiskevicius S, Vanseviciute-Petkeviciene R, Usinskiene J, Briediene R, Bulotiene G, Stratilatovas E, Ostapenko V, Gibaviciene J, Karnas I, Kekstaite S, Navickiene J, Ulys A, Zalimas A, Sruogis A, Kardelis Z, Zaremba S, Askinis R, Cicenas S, Tikuisis R, Ciurliene R, Jarmalaite S. Dabkeviciene D, et al. Among authors: cicenas s. Healthcare (Basel). 2021 Nov 9;9(11):1522. doi: 10.3390/healthcare9111522. Healthcare (Basel). 2021. PMID: 34828568 Free PMC article.
Cell-free DNA in non-small cell lung cancer.
Gedvilaitė V, Schveigert D, Cicėnas S. Gedvilaitė V, et al. Among authors: cicenas s. Acta Med Litu. 2017;24(2):138-144. doi: 10.6001/actamedica.v24i2.3495. Acta Med Litu. 2017. PMID: 28845132 Free PMC article.
54 results